Delivery Order SPE2DB22D2206-SPE2DB25FEJ54
- Not listed
- This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $7,030.77 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 10, 2024, with a completion date of January 2, 2025. The contract is a delivery order without any set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite...
- This federal contract award is for the pharmaceutical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,530.60 Firm Fixed Price Delivery Order contract was awarded by the Defense Logistics Agency (DLA), with an ultimate completion date of December 2, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML pharmaceutical products to the Defense Logistics Agency (DLA). The $4,687.18 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on November 20, 2024, with a completion date of December 12, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
- This federal contract award, valued at $9,374.36, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with a performance period ending on December 23, 2024. This award is a delivery order against Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA,...
- This federal contract award is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 6, 2024, with a ceiling value of $7,030.77 and a completion date of December 30, 2024. This contract is a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,687.18 firm fixed price delivery order is for the medical product TEZSPIRE 210 MG/1.91 ML PEN 1.91ML. The contract has an ultimate completion date of February 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as a primary vehicle for...
- The federal contract award summarized is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, to the Defense Logistics Agency (DLA) Medical Supply Chain. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on December 18, 2024 with a ceiling value of $2,343.59. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of January 10, 2025. There was no set-aside designation for this...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,687.18, is a delivery order for the medical product "TEZSPIRE 210 MG/1.91 ML PEN 1.91ML." The contract has an ultimate completion date of April 14, 2025 and is a firm fixed-price contract. There is no set-aside designation for this award. Amerisourcebergen holds a significant...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,374.36 firm fixed-price delivery order is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product. The contract has an ultimate completion date of April 9, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp is a $13,591.74 delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract, which has a ceiling value of up to $999,999,999 through December 2025. The contract is for the supply of TEZSPIRE 210 MG/1.91 ML PEN 1.91ML, a pharmaceutical product, with an ultimate completion date of September 24, 2024. Amerisourcebergen, a major pharmaceutical distributor, is the prime contractor for this award,...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FEJ54Delivery Order
This federal contract award is for the medical product "TEZSPIRE 210 MG/1.91 ML PEN 1.91ML" and was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order valued at $9,374.36 with a firm fixed price and a completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which is valued at $999,999,999 and runs through November 2026. The IDC enables the DLA to efficiently procure a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, generic and brand-name drugs, vaccines, syringes, and other medical commodities to support military healthcare programs globally. This particular contract award did not have a set-aside designation, indicating open competition. Amerisourcebergen, as a major pharmaceutical distributor and healthcare solutions provider, plays a critical role in supplying medical products to federal government agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.4k | 11/21/24 |